|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-8-12
|
|
pubmed:abstractText |
Interleukin 1beta (IL-1beta) is a multifunctional cytokine that up-regulates the inflammatory response. It is not known whether IL-1beta plays a major role in human malignancy. To determine whether IL-1beta might be involved in breast carcinoma progression, the authors measured the IL-1beta content in tissue extracts from >200 invasive breast carcinomas and smaller numbers of ductal carcinoma in situ (DCIS) and benign lesions.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:AndresJJ,
pubmed-author:FuchsAA,
pubmed-author:GoldbergI DID,
pubmed-author:GuidaAA,
pubmed-author:HastingsH MHM,
pubmed-author:JinLL,
pubmed-author:JosephAA,
pubmed-author:PolveriniP JPJ,
pubmed-author:RosenE MEM,
pubmed-author:SchnittS JSJ,
pubmed-author:SchwalmSS,
pubmed-author:TunçerAA,
pubmed-author:YauSS,
pubmed-author:YuanR QRQ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
421-34
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:9241076-Biological Markers,
pubmed-meshheading:9241076-Breast Neoplasms,
pubmed-meshheading:9241076-Carcinoma, Ductal, Breast,
pubmed-meshheading:9241076-Carcinoma in Situ,
pubmed-meshheading:9241076-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:9241076-Hepatocyte Growth Factor,
pubmed-meshheading:9241076-Humans,
pubmed-meshheading:9241076-Immunohistochemistry,
pubmed-meshheading:9241076-Interleukin-1,
pubmed-meshheading:9241076-Lymphatic Metastasis,
pubmed-meshheading:9241076-Prognosis,
pubmed-meshheading:9241076-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:9241076-Receptor, erbB-2,
pubmed-meshheading:9241076-Receptors, Estrogen,
pubmed-meshheading:9241076-Receptors, Progesterone,
pubmed-meshheading:9241076-Tumor Necrosis Factor-alpha,
pubmed-meshheading:9241076-von Willebrand Factor
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Expression of interleukin-1beta in human breast carcinoma.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for Albert Einstein College of Medicine, New Hyde Park, New York 11040, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
